Gynecologists support the project under consideration to extend the recommendation for the Human Papillomavirus (HPV) vaccine, a cervical cancer virus, to boys. The FNCGM
"universal vaccination (girls and boys aged 11 to 14 years with a catch of up to 19 years) would reduce the number of cancers caused by HPV by a multiple important population," said FNCGM president dr. Pia de Reilhac.
Current vaccine mainly affects girls.
In France, vaccination is now recommended and reimbursed to all girls aged 11 to 14 years and between 1
According to a draft opinion released on October 30, the High Health Authority (HAS) plans to extend this recommendation to boys "for the transfer" of HPV. The Health Department had been contacted by the Ministry of Health with this matter.
"Medical gynecologists have given a very positive opinion from the (National) Federation of Medical Gynecology (FNCGM) on this recommendation," said the FNCGM, according to which they are subject to public consultation until the 27th of FNCGM
Prevention of Infections and Cancers
HPV-related sexually transmitted infections may occur years later cancers in women and men in the cervix, vagina, penis, anus or throat.  In France, there are approximately 1,750 new cases of HPV-related cancer in men and 4,580 in women every year.
The only cancer of the cervix still kills 1,100 women a year in France and 2,900 women are diagnosed with new cases  Some countries, such as the United States, already recommend that all adolescents aged 11 or 12 be vaccinated against HPV before they are exposed to this virus risk.